AB 1103: Faster Pathways for Psychedelics and Controlled-Substance Research in California

Health & Plant Medicines /

After a few failed attempts, could psychedelics be moving closer to a legal regulated market in California? Recently, Governor Newsom signed AB 1103 that would authorize the Research Advisory Panel of California (“RAPC”) to expedite review of research of psychedelics to treat conditions such as depression and PTSD until January 1,2028. RAPC is responsible for […]

AB 1103: Faster Pathways for Psychedelics and Controlled-Substance Research in California Read More »

Psilocybin Legalization Across the US: A Comprehensive Overview

Health & Plant Medicines /

Psilocybin Legalization Across the US: A Comprehensive Overview Across the country, there are many folks who are pushing for legislative change pertaining to certain psychedelic substances currently under schedule I drugs. Psychedelics, such as psilocybin and MDMA, have shown promising results in treating mental health disorders, including depression, anxiety, and PTSD. As a result, state

Psilocybin Legalization Across the US: A Comprehensive Overview Read More »

Menu
Menu
Instagram Linkedin
Subscribe